Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019835

See Plans and Pricing

« Back to Dashboard

NDA 019835 describes ZYRTEC HIVES RELIEF, which is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from one supplier. Additional details are available on the ZYRTEC HIVES RELIEF profile page.

The generic ingredient in ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-four suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for 019835

Tradename:	ZYRTEC HIVES RELIEF
Applicant:	J And J Consumer Inc
Ingredient:	cetirizine hydrochloride
Patents:	0
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 019835

Anti-Allergic Agents
Histamine H1 Antagonists, Non-Sedating

Suppliers and Packaging for NDA: 019835

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZYRTEC ALLERGY	cetirizine hydrochloride	TABLET;ORAL	019835	NDA	Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division	50580-726	50580-726-03	50 BLISTER PACK in 1 CARTON (50580-726-03) > 1 TABLET, FILM COATED in 1 BLISTER PACK
ZYRTEC ALLERGY	cetirizine hydrochloride	TABLET;ORAL	019835	NDA	Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division	50580-726	50580-726-13	3 BLISTER PACK in 1 CARTON (50580-726-13) > 1 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Nov 16, 2007	TE:		RLD:	Yes

Profile for product number 004

Active Rx/OTC/Discontinued:	OTC	Dosage:	TABLET;ORAL			Strength	10MG
Approval Date:	Nov 16, 2007	TE:		RLD:	Yes

Profile for product number 005

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Nov 16, 2007	TE:		RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

McKesson

McKinsey

Express Scripts

Baxter

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.